COVID-19, glomerulonefritis ANCA y anti-membrana basal glomerular. Caso clínico
Palabras clave:
Antibodies, Antineutrophil Cytoplasmic, Anti-Glomerular Basement Membrane Disease, Covid-19, Glomerulonephritis, PlasmapheresisResumen
Renal involvement in COVID-19 infection is varied and worsens its outcome and prognosis. However, the association of COVID infection with glomerulonephritis is exceptional. We report a 46-year-old woman with COVID-19 who had an acute kidney injury and ANCA associated glomerulonephritis two weeks after the onset of the disease. The kidney biopsy showed a crescentic glomerulonephritis and the presence of anti-glomerular basement membrane antibodies (GBM-Abs). She was treated with steroids and oral cyclophosphamide with good response without requiring plasmapheresis. Plasma anti GBM-Abs were negative. This case suggests that the presence of anti-GBM-Abs in the kidney, was temporally related to COVID-19 pulmonary damage. The absence of plasma antibodies is probably due to transient production and glomerular adsorption, but with unknown pathogenic role.Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2022-09-12
Cómo citar
Briones, E., Méndez, G. P., Laguna, J., & Vargas, M. (2022). COVID-19, glomerulonefritis ANCA y anti-membrana basal glomerular. Caso clínico. Revista Médica De Chile, 150(6). Recuperado a partir de https://mail.revistamedicadechile.cl/index.php/rmedica/article/view/9883
Número
Sección
Reporte de Caso Clínico